133 related articles for article (PubMed ID: 23328240)
1. [Baseline analysis of refractory primary biliary cirrhosis].
Wang L; Kong F; Zhang X; Xu D; Hu ZJ; Li YZ; Zhang FC
Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2918-20. PubMed ID: 23328240
[TBL] [Abstract][Full Text] [Related]
2. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
Corpechot C; Abenavoli L; Rabahi N; Chrétien Y; Andréani T; Johanet C; Chazouillères O; Poupon R
Hepatology; 2008 Sep; 48(3):871-7. PubMed ID: 18752324
[TBL] [Abstract][Full Text] [Related]
3. [Clinical features of patients with primary biliary cirrhosis and anti-SP100 autoantibody positivity].
Tang YM; Bao WM; You LY; Jiang HJ; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):359-62. PubMed ID: 24025137
[TBL] [Abstract][Full Text] [Related]
4. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
5. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
[TBL] [Abstract][Full Text] [Related]
6. B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid.
Myers RP; Swain MG; Lee SS; Shaheen AA; Burak KW
Am J Gastroenterol; 2013 Jun; 108(6):933-41. PubMed ID: 23649186
[TBL] [Abstract][Full Text] [Related]
7. Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis.
Zhu YJ; Li J; Liu YG; Jiang Y; Cheng XJ; Han X; Wang CY; Li J
World J Gastroenterol; 2023 Sep; 29(34):5075-5081. PubMed ID: 37753365
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
[TBL] [Abstract][Full Text] [Related]
9. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome.
Corpechot C; Chazouillères O; Poupon R
J Hepatol; 2011 Dec; 55(6):1361-7. PubMed ID: 21703194
[TBL] [Abstract][Full Text] [Related]
10. Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid.
Takeuchi Y; Ikeda F; Fujioka S; Takaki T; Osawa T; Yasunaka T; Miyake Y; Takaki A; Iwasaki Y; Kobashi H; Yamamoto K; Itoshima T
J Gastroenterol Hepatol; 2011 Sep; 26(9):1395-401. PubMed ID: 21443659
[TBL] [Abstract][Full Text] [Related]
11. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
Poupon RE; Balkau B; Eschwège E; Poupon R
N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics of primary biliary cirrhosis: a report of 45 cases].
Zhang F; Jia J; Wang B; Qian L; Yin S; Wang Y; Cui Y; You H; Ma H; Wang H; Zhang C
Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):163-7. PubMed ID: 11940315
[TBL] [Abstract][Full Text] [Related]
14. [Liver histopathology, clinical features and prognostic factors of primary biliary cirrhosis: an analysis of 60 cases].
Yao Y; Xu ZY; Gao JP; Chen XP; Shen LJ; Yang LH; You LY; Yang JH
Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):457-60. PubMed ID: 18578999
[TBL] [Abstract][Full Text] [Related]
15. Natural history of pruritus in primary biliary cirrhosis.
Talwalkar JA; Souto E; Jorgensen RA; Lindor KD
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):297-302. PubMed ID: 15017671
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of primary biliary cirrhosis: a report of 42 cases].
Dai Y; Liang YH; Xie PY; Chen BW; Liu XG
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):410-4. PubMed ID: 16086064
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features of early- and late-stage primary biliary cirrhosis: a comparative study].
Zhao SX; Zhang YG; Zhou GD; Wang RQ; Zhang QS; Li WC; Ren WG; Nan YM; Zhao JM
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):412-6. PubMed ID: 27465943
[TBL] [Abstract][Full Text] [Related]
18. [The clinical characteristics of primary biliary cirrhosis in China: a systematic review].
Gu EL; Yao GB
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):861-6. PubMed ID: 19958649
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
Wolfhagen FH; van Buuren HR; Schalm SW
Neth J Med; 1994 Mar; 44(3):84-90. PubMed ID: 8202208
[TBL] [Abstract][Full Text] [Related]
20. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.
Cavazzana I; Ceribelli A; Taraborelli M; Fredi M; Norman G; Tincani A; Satoh M; Franceschini F
J Rheumatol; 2011 Oct; 38(10):2180-5. PubMed ID: 21921093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
